These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation. Dan GA; Gonţa A Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649 [TBL] [Abstract][Full Text] [Related]
5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
6. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Frick M; Darpö B; Ostergren J; Rosenqvist M Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter. Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591 [TBL] [Abstract][Full Text] [Related]
8. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter]. Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224 [TBL] [Abstract][Full Text] [Related]
9. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]. Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720 [TBL] [Abstract][Full Text] [Related]
10. Sotalol for atrial tachycardias after surgery for congenital heart disease. Beaufort-Krol GC; Bink-Boelkens MT Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2125-9. PubMed ID: 9272523 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. Reimold SC; Lamas GA; Cantillon CO; Antman EM Am Heart J; 1995 Jun; 129(6):1127-32. PubMed ID: 7754943 [TBL] [Abstract][Full Text] [Related]
12. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation. Yeşil M; Bayata S; Postaci N; Yücel O; Aslan O Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation. Tse HF; Lau CP J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228 [TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735 [TBL] [Abstract][Full Text] [Related]
15. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study]. Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808 [TBL] [Abstract][Full Text] [Related]
17. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355 [TBL] [Abstract][Full Text] [Related]
18. Long-term effect of VVI pacing on atrial and ventricular function in patients with sick sinus syndrome. Paxinos G; Katritsis D; Kakouros S; Toutouzas P; Camm AJ Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):728-34. PubMed ID: 9584304 [TBL] [Abstract][Full Text] [Related]
19. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]